GH (Guardant Health, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Guardant Health, Inc. Common Stock (GH) is a publicly traded Healthcare sector company. As of May 20, 2026, GH trades at $112.54 with a market cap of $12.68B and a P/E ratio of -33.50. GH moved +17.08% today. Year to date, GH is +12.86%; over the trailing twelve months it is +187.64%. Its 52-week range spans $20.14 to $120.74. Analyst consensus is strong buy with an average price target of $128.88. Rallies surfaces GH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns GH stock?

Hedge funds tracked by Rallies that own GH include Temasek Holdings, Orbimed Advisors, Polen Capital, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Guardant Health, Inc. Common Stock.

GH Key Metrics

Key financial metrics for GH
MetricValue
Price$112.54
Market Cap$12.68B
P/E Ratio-33.50
EPS$-3.32
Dividend Yield0.00%
52-Week High$120.74
52-Week Low$20.14
Volume4.14M
Avg Volume0
Revenue (TTM)$982.02M
Net Income$-416.28M
Gross Margin64.46%

Top Hedge Funds Holding GH

  • Temasek Holdings holds 985.57K shares of GH, changed -5.61% as of Mar 31, 2026.
  • Orbimed Advisors holds 435.20K shares of GH, changed +0.00% as of Mar 31, 2026.
  • Polen Capital holds 34.73K shares of GH, changed +76.56% as of Mar 31, 2026.
  • Bridgewater Associates holds 13.35K shares of GH, changed -52.81% as of Mar 31, 2026.
  • Mangrove Partners holds 10.74K shares of GH, changed -31.45% as of Dec 31, 2025.

Latest GH News

Recent GH Insider Trades

  • Tariq Musa sold 116 (~$11.13K) on May 18, 2026.
  • Talasaz AmirAli sold 50.00K (~$5.02M) on May 12, 2026.
  • Tariq Musa sold 116 (~$9.84K) on Apr 16, 2026.

GH Analyst Consensus

19 analysts cover GH: 0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $128.88.

Common questions about GH

Who owns GH stock?
Hedge funds tracked by Rallies that own GH include Temasek Holdings, Orbimed Advisors, Polen Capital, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Guardant Health, Inc. Common Stock.
Does Rallies show 13F holders for GH?
Yes. Rallies tracks hedge fund and 13F ownership data for GH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GH. It does not provide personalized investment advice.
GH

GH